Gelteq is trading at $0.54 (-11.70%), with no clear catalyst identified for September 23, 2026.
- No company-specific announcement was identified; Gelteq’s investor-relations page showed no September 22 announcement.
- The decline is occurring despite biotechnology sector strength, with XBI up 2.07%.
- Broader indexes were only modestly lower, leaving the selling pressure unexplained.